Eli Gilboa is at the Center for Genetic and Cellular Therapies, Department of Surgery, Duke University, Durham, North Carolina 27710, USA. e.gilboa@cgct.duke.edu
siRNA-mediated inhibition of SOCS1 function enhances the immunostimulatory capacity of dendritic cells and may lead to more effective cancer vaccines.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
